BORRELIOOSIROKOTE

[Bb]

Lähettäjä: Soijuv Lähetetty: 20.12.2004 17:44

Tutkijat ovat selvittäneet borreliabakteerin leviämiseen
vaikuttavat mekanismit ja proteiinit. Löytö edistää
rokotteen kehittämistä. Saapa nähdä onko siitä hyötyä
borreliabakteerin eri alalajeihin yms.


Key advance in understanding the proteins and mechanisms involved in the
spread of Lyme Disease
Posted By: News-Medical in Disease/Infection News
Published: Thursday, 16-Dec-2004
http://www.news-medical.net/print_article.asp?id=6871

Virginia Commonwealth University scientists have made a key advance in
understanding the proteins and mechanisms involved in the spread of Lyme
Disease, a finding that could lead to a vaccine against the tick-borne
illness that affects thousands of people each year.
In the December issue of the Journal of Immunology, the researchers
characterized the molecular interaction that occurs between an important
virulence factor in Lyme disease spirochetes, known as OspE, and a host
protein, factor H (fH), which is an important regulator of the immune
system. It is the binding of fH by the Lyme disease pathogens that allows
the bacteria to avoid being destroyed by the host, according to the article.
Defining the nature of the interaction between fH binding proteins and fH
may facilitate the development of a new generation of vaccines against the
bacteria.

?Understanding the complex interaction between the different residues and
structural elements of these key proteins involved in the pathogenesis of
Lyme Disease is a significant step forward in our research,? said Richard T.
Marconi, Ph.D., associate professor of microbiology and immunology at VCU.

Lyme disease spirochetes use fH-binding as a virulence mechanism ? an
ability that has also been observed in several other dangerous pathogens,
including those responsible for HIV; various species of Neisseria, which
cause diseases like meningitis and gonorrhea; and some types of parasites.

?In addition, what we have learned in our study of fH binding by the Lyme
disease bacteria can be applied to vaccine development for other organisms
that bind fH as well,? he said.

Leading one of the largest Lyme Disease research efforts in the country,
Marconi?s lab demonstrated that fH-binding by OspE was dependent on the
formation of specific structural elements. Disruption of these structural
elements resulted in the loss of the fH-binding capability.

?For example, the use of modified forms of OspE that can not bind fH as a
vaccinogen may elicit an immune response that will prevent the pathogen from
binding fH and thus the bacteria will no longer be able to persist in an
infected individual,? he said. ?The modification of fH binding proteins may
allow for the development of a novel class of proteins that can be used in
the development of a Lyme disease vaccine.?

Studies are currently under way to determine if these modified proteins will
offer improved protection against Lyme Disease.

Lyme disease is extremely difficult to diagnose and no reliable test or
vaccine is currently available. It is transmitted by the bite of an infected
Ixodes tick. Ticks are able to survive under a variety of conditions as long
as adequate moisture is available. In the United States, the peak season for
ticks is April to September in the northeast, and from November to April in
the west.

Marconi?s research is supported by three grants from the National Institutes
of Health, totaling about $4 million. He collaborated with John McDowell,
Ph.D., a postdoctoral fellow in the VCU?s Department of Microbiology and
Immunology.

http://www.vcu.edu